TRAIL: At the center of drugable anti-tumor pathways

14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Molecular analysis in vivo and in vitro has identified TRAIL as a central component of anti-cancer networks in the cell. More recently, TRAIL has been shown to be involved in the selective apoptosis of AML cells by histone deacetylase inhibitors (HDACi). Here we summarize findings that the TRAIL pathway is a key factor in the apoptotic action of HDACi, as well as, retinoids and retinoid-combinations. ©2005 Landes Bioscience.

Cite

CITATION STYLE

APA

Clarke, N., Nebbioso, A., Altucci, L., & Gronemeyer, H. (2005). TRAIL: At the center of drugable anti-tumor pathways. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.4.7.1822

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free